Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)
Cells · 11.07.2024 · 13 (14) · 1180
DOI: 10.3390/cells13141180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.07.2024. Verfasst von Marco Caminati und 31 weiteren Autor:innen. Beteiligte Einrichtung: Asthma Centre and Allergy Unit, Center for Hypereosinophilic Dysimmune Diseases, Department of Medicine, University of Verona, 37124 Verona, Italy. Hauptthemen laut MEDLINE: Hypereosinophilic Syndrome. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypereosinophilic syndrome (HES) encompasses a heterogeneous and complex group of different subtypes within the wider group of hypereosinophilic disorders. Despite increasing research interest, several unmet needs in terms of disease identification, pathobiology, phenotyping, and personalized treatment remain to be addressed. Also, the prospective burden of non-malignant HES and, more in general, HE disorders is currently unknown. On a practical note, shortening the diagnostic delay and the time to an appropriate treatment approach probably represents the most urgent issue, even in light of the great impact of HES on the quality of life of affected patients. The present document represents the first action that the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) has finalized within a wider project aiming to establish a collaborative national network on HES (InHES—Italian Network on HES) for patients and physicians. The first step of the project could not but focus on defining a common language as well as sharing with all of the medical community an update on the most recent advances in the field. In fact, the existing literature has been carefully reviewed in order to critically integrate the different views on the topic and derive practical recommendations on disease identification and treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Asthma Centre and Allergy Unit, Center for Hypereosinophilic Dysimmune Diseases, Department of Medicine, University of Verona, 37124 Verona, Italy.
- SSDDU Immunologia Clinica ed Allergologia, AO Mauriziano, 10128 Turin, Italy.
- Health Directorate, Verona Integrated University Hospital, 35134 Verona, Italy.
- Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, 70126 Bari, Italy.
- Department of Diagnostics and Public Health, University of Verona, 37126 Verona, Italy.
- Allergologia dell'Istituto di Clinica Medica del Policlinico Gemelli, Università Cattolica di Roma, 00168 Rome, Italy.
ORCID-Profile: Marco Caminati, Luisa Brussino, Palma Carlucci, Cristiano Caruso, Lorenzo Cosmi, Simona D'Amore, Aikaterini Detoraki, Mario Di Gioacchino, Ilaria Mormile, Francescopaolo Granata, Mauro Krampera, Fabrizio Pane, Paola Parronchi, Girolamo Pelaia, Francesca Wanda Rossi, Gianenrico Senna, Massimo Triggiani, Angelo Vacca, Alessandra Vultaggio, Amato de Paulis
Zitieren
APA
Caminati, M., Brussino, L., Carlucci, M., Carlucci, P., Carpagnano, L. F., Caruso, C., Cosmi, L., D'Amore, S., Del Giacco, S., Detoraki, A., Di Gioacchino, M., Matucci, A., Mormile, I., Granata, F., Guarnieri, G., Krampera, M., Maule, M., Nettis, E., Nicola, S., …, & de Paulis, A. (2024). Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC). Cells, 13(14), 1180. https://doi.org/10.3390/cells13141180
Vancouver
Caminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano LF, Caruso C, et al. Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC). Cells. 2024;13(14):1180. doi:10.3390/cells13141180
BibTeX
@article{Caminati2024,
author = {Caminati, Marco and Brussino, Luisa and Carlucci, Matilde and Carlucci, Palma and Carpagnano, Lucia Federica and Caruso, Cristiano and Cosmi, Lorenzo and D'Amore, Simona and Del Giacco, Stefano and Detoraki, Aikaterini and Di Gioacchino, Mario and Matucci, Andrea and Mormile, Ilaria and Granata, Francescopaolo and Guarnieri, Gabriella and Krampera, Mauro and Maule, Matteo and Nettis, Eustachio and Nicola, Stefania and Noviello, Silvia and Pane, Fabrizio and Papayannidis, Cristina and Parronchi, Paola and Pelaia, Girolamo and Ridolo, Erminia and Rossi, Francesca Wanda and Senna, Gianenrico and Triggiani, Massimo and Vacca, Angelo and Vivarelli, Emanuele and Vultaggio, Alessandra and de Paulis, Amato},
title = {Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)},
journal = {Cells},
year = {2024},
volume = {13},
number = {14},
pages = {1180},
doi = {10.3390/cells13141180}
}
EUVIMED